Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use. (Q33864810)

29 July 2017

1 reference

title

Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use. (English)

1 reference

29 July 2017

Mørland J

1

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

112-113

1 reference

29 July 2017

147-152

1 reference

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Ecstasy and Whizz at a rave resulting in a major burn plus complications

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Drugged driving, a review based on the experience in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Subjective reports of the effects of MDMA in a clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Low-dose MDMA ("ecstasy") induces vasopressin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

"Saturday night fever": ecstasy related problems in a London accident and emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900217-9

7 January 2021

10.1016/S0378-4274(99)00217-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10720724